# Leukemic appendix with clinical presentation that mimics acute appendicitis

**Authors:** Oren Weiss, Yanhua Wang

PMC · DOI: 10.1007/s12308-026-00681-x · Journal of Hematopathology · 2026-02-05

## TL;DR

This paper presents a rare case of a woman with a leukemic appendix that mimicked acute appendicitis.

## Contribution

The novelty lies in describing an unusual complication of AML in a patient in remission.

## Key findings

- AML can lead to rare complications such as leukemic appendix.
- Clinical presentation of leukemic appendix can resemble acute appendicitis.
- This case highlights the need for careful diagnosis in AML patients.

## Abstract

Acute myeloid leukemia (AML) is a malignant neoplasm characterized by the uncontrolled, clonal growth of hematopoietic cells. It is the most common acute leukemia in adults, with a median age at diagnosis of 69 years and an incidence of 4.2 cases and mortality of 2.7 per 100,00 people per year in the USA, as reported by SEER (2025) and Shallis et al. (Blood Rev 36:70–87, 2019). With the advent of more detailed molecular studies, next-generation sequencing, and novel therapies, the prognosis for patients with AML has significantly improved, as discussed by Shimony et al. (Am J Hematol 98(3):502–526, 2023). However, there are numerous complications of treatment and progression of disease that can affect patients’ quality of life and overall survival, as detailed by Khwaja et al. (Nat Rev Dis Primer 2(1):1–22, 2016). Below, we describe an unusual complication of AML in a woman who previously achieved complete remission.

## Linked entities

- **Diseases:** Acute myeloid leukemia (MONDO:0015667), AML (MONDO:0018874), acute appendicitis (MONDO:0005649)

## Full-text entities

- **Genes:** IL3RA (interleukin 3 receptor subunit alpha) [NCBI Gene 3563] {aka CD123, IL-3R-alpha, IL3R, IL3RAY, IL3RX, IL3RY}, KIT (KIT proto-oncogene, receptor tyrosine kinase) [NCBI Gene 3815] {aka C-Kit, CD117, MASTC, PBT, SCFR}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, MME (membrane metalloendopeptidase) [NCBI Gene 4311] {aka CALLA, CD10, CMT2T, NEP, SCA43, SFE}, LYZ (lysozyme) [NCBI Gene 4069] {aka AMYLD5, LYZF1, LZM}, IDH1 (isocitrate dehydrogenase (NADP(+)) 1) [NCBI Gene 3417] {aka HEL-216, HEL-S-26, IDCD, IDH, IDP, IDPC}, FLT3 (fms related receptor tyrosine kinase 3) [NCBI Gene 2322] {aka CD135, FLK-2, FLK2, STK1}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, NPM1 (nucleophosmin 1) [NCBI Gene 4869] {aka B23, NPM}, ITGAX (integrin subunit alpha X) [NCBI Gene 3687] {aka CD11C, SLEB6}, CD7 (CD7 molecule) [NCBI Gene 924] {aka GP40, LEU-9, TP41, Tp40}, CD34 (CD34 molecule) [NCBI Gene 947], MPO (myeloperoxidase) [NCBI Gene 4353], ANPEP (alanyl aminopeptidase, membrane) [NCBI Gene 290] {aka AP-M, AP-N, APN, CD13, GP150, LAP1}, CD33 (CD33 molecule) [NCBI Gene 945] {aka CD33rSiglec, SIGLEC-3, SIGLEC3, p67}, CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, CD2 (CD2 molecule) [NCBI Gene 914] {aka LFA-2, SRBC, T11}
- **Diseases:** tachycardia (MESH:D013610), tenderness (MESH:D063806), Leukemic appendix (MESH:D001063), anemia (MESH:D000740), uterine bleeding (MESH:D014592), obesity (MESH:D009765), Myeloid sarcomas (MESH:D023981), leukocytosis (MESH:D007964), Appendicitis (MESH:D001064), solid (MESH:D018250), asthma (MESH:D001249), thrombocytopenia (MESH:D013921), leukemic (MESH:D007938), malignant neoplasm (MESH:D009369), AML (MESH:D015470), pancytopenia (MESH:D010198), abdominal pain (MESH:D015746), myelodysplastic syndromes (MESH:D009190), myeloid leukemia (MESH:D007951), inflammation (MESH:D007249), bone marrow (MESH:D001855), pain (MESH:D010146), fever (MESH:D005334)
- **Chemicals:** cytarabine (MESH:D003561), H&amp;E (MESH:D006371), idarubicin (MESH:D015255)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12876070/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12876070/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12876070/full.md

---
Source: https://tomesphere.com/paper/PMC12876070